- Kristensen VN, Lingjaerde OC, Russnes HG
et al (2014) Principles and methods of inte-
grative genomic analyses in cancer. Nat Rev
Cancer 14:299–313 - Storey JD, Tibshirani R (2003) SAM thresh-
olding and false discovery rates for detecting
differential gene expression in DNA Microar-
rays. In: Irizarry RA (ed) The analysis of gene
expression data: methods and software.
Springer, New York, NY, pp 272–290 - Kerr MK, Martin M, Churchill G (2000)
Analysis of variance for gene expression
microarray data. J Comput Biol 7:819–837 - Baldi P, Long AD (2001) A Bayesian frame-
work for the analysis of microarray expression
data: regularized t-test and statistical infer-
ences of gene changes. Bioinformatics
17:509–519 - Wu TD (2001) Analysing gene expression
data from DNA microarrays to identify candi-
date genes. J Pathol 195(1):53–65 - Tomczak K, Czerwin ́ska P, Wiznerowicz M
(2015) The Cancer Genome Atlas (TCGA):
an immeasurable source of knowledge. Con-
temp Oncol (Pozn) 19(1A):A68–A77 - Hudson TJ, Anderson W, Aretz A et al (2010)
International network of cancer genome pro-
jects. Nature 464:993–998 - Siegel RL, Miller KD, Jemal A (2016) Cancer
statistics. CA Cancer J Clin 66:7–30 - Varambally S, Dhanasekaran SM, Zhou M
et al (2002) The polycomb group protein
EZH2 is involved in progression of prostate
cancer. Nature 419:624–629 - Barton BE, Karras JG, Murphy TF et al
(2004) Signal transducer and activator of
transcription 3 (STAT3) activation in prostate
cancer: Direct STAT3 inhibition induces apo-
ptosis in prostate cancer lines. Mol Cancer
Ther 3:11–20 - Abdulghani J, Gu L, Dagvadorj A et al (2008)
Stat3 promotes metastatic progression of
prostate cancer. Am J Pathol 172:1717–1728 - Nair S, Barve A, Khor T-O et al (2010) Regu-
lation of Nrf2- and AP-1-mediated gene
expression by epigallocatechin-3-gallate and
sulforaphane in prostate of Nrf2-knockout
or C57BL/6J mice and PC-3 AP-1 human
prostate cancer cells. Acta Pharmacol Sin
31:1223–1240 - Mehta HH, Gao Q, Galet C et al (2011)
IGFBP-3 is a metastasis suppression gene in
prostate cancer. Cancer Res 71:5154–5163 - Taylor BS, Schultz N, Hieronymus H et al
(2011) Integrative genomic profiling of
human prostate cancer. Cancer Cell 18:11–22
89. Bengtsson H, Wirapati P, Speed TP (2009) A
single-array preprocessing method for esti-
mating full-resolution raw copy numbers
from all Affymetrix genotyping arrays includ-
ing GenomeWideSNP 5 & 6. Bioinformatics
25:2149–2156
90. Ritchie ME, Phipson B, Wu D et al (2015)
limma powers differential expression analyses
for RNA-sequencing and microarray studies.
Nucleic Acids Res 43:e47
91. Matys V, Fricke E, Geffers R et al (2003)
TRANSFAC: transcriptional regulation,
from patterns to profiles. Nucleic Acids Res
31:374–378
92. Chou C-H, Chang N-W, Shrestha S et al
(2016) miRTarBase 2016: updates to the
experimentally validated miRNA-target inter-
actions database. Nucleic Acids Res 44(D1):
D239–D247
93. Betel D, Koppal A, Agius P et al (2010) Com-
prehensive modeling of microRNA targets
predicts functional non-conserved and
non-canonical sites. Genome Biol 11:R90
94. Agarwal V, Bell GW, Nam J-W et al (2015)
Predicting effective microRNA target sites in
mammalian mRNAs. eLife 4:PMC4532895
95. Cai Y, Yu X, Hu S et al (2009) A brief review
on the mechanisms of miRNA regulation.
Genomics Proteomics Bioinformatics
7:147–154
96. Lorio MV, Croce CM (2012) MicroRNA dys-
regulation in cancer: diagnostics, monitoring
and therapeutics. A comprehensive review.
EMBO Mol Med 4:143–159
97. Lai X, Schmitz U, Gupta SK et al (2012)
Computational analysis of target hub gene
repression regulated by multiple and coopera-
tive miRNAs. Nucleic Acids Res
40:8818–8834
98. Wang L, Chen S, Xue M et al (2012) Homeo-
box D10 gene, a candidate tumor suppressor,
is downregulated through promoter hyper-
methylation and associated with gastric carci-
nogenesis. Mol Med 18:389–400
99. Yu Y, Liu L, Xie N et al (2013) Expression and
function of the progesterone receptor in
human prostate stroma provide novel insights
to cell proliferation control. J Clin Endocrinol
Metab 98:2887–2896 - Bonkhoff H, Fixemer T, Hunsicker I et al
(2001) Progesterone receptor expression in
human prostate cancer: correlation with
tumor progression. Prostate 48:285–291 - Li M, Ma H, Yang L et al (2016) Mangiferin
inhibition of proliferation and induction of
apoptosis in human prostate cancer cells is
Integrative Workflow for Predicting Disease Signatures 275